REALCME Case Challenge

Release Date:    Friday, October 31, 2014
Expiration Date:    Friday, October 30, 2015
Estimated Time To Complete Activity:    1 hour

This CME-certified interactive text module activity developed by Robert A. Burger, MD, FACOG, FACS, and Krishnansu S. Tewari, MD, FACOG, FACS, leading gynecologic oncology experts, will provide a concise review of recent clinical advances in cervical cancer, including preventative, diagnostic, and therapeutic strategies. The recent approval of bevacizumab by the US FDA will also be featured. The curriculum of this activity will assist clinicians with optimal integration of evolving evidence regarding cervical cancer into individualized treatment planning.

To participate in this activity, please click on the ‘Launch’ button. You will be redirected to Note: If page does not load immediately, please clear your browser's cache and try again.

Fee Statement
There is no fee for this educational activity.

Technical Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above
For video playback, install the latest version of Flash or Quicktime.

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Physician Continuing Medical Education
Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and AXIS Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Upon successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.To contact PIM, please visit

Jointly provided by

This activity is supported by an independent educational grant from Genentech.